NasdaqGM - Nasdaq Real Time Price USD
Arcturus Therapeutics Holdings Inc. (ARCT)
12.65
+0.48
+(3.94%)
At close: April 23 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BARLOW JAMES F. Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 13,131 |
| CHIVUKULA PADMANABH Chief Operating Officer | Sale | Oct 15, 2024 | 435,334 |
| FARRELL PETER CRAIG Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 98,696 |
| HOLMES EDWARD W. Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 3,131 |
| KUMMERFELD KEITH C Officer | Sale | Jul 14, 2023 | 950 |
| MARANTZ JING L. Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 3,131 |
| MARKELS JOHN Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 3,131 |
| MARQUET MAGDA Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 28,073 |
| PAYNE JOSEPH E Chief Executive Officer | Purchase | Nov 23, 2022 | 1,480,100 |
| SASSINE ANDY H Chief Financial Officer | Sale | Jun 12, 2024 | 220,526 |
Related Tickers
EDIT Editas Medicine, Inc.
1.5600
0.00%
PHAT Phathom Pharmaceuticals, Inc.
4.0200
+1.52%
VIR Vir Biotechnology, Inc.
5.97
+2.93%
IMVT Immunovant, Inc.
14.45
+1.40%
NTLA Intellia Therapeutics, Inc.
8.09
-2.65%
DNLI Denali Therapeutics Inc.
14.87
+1.85%
RARE Ultragenyx Pharmaceutical Inc.
37.31
+3.90%
CAPR Capricor Therapeutics, Inc.
13.15
-5.33%
CVAC CureVac N.V.
3.1700
-0.63%
OCUL Ocular Therapeutix, Inc.
7.85
-0.76%